Showing results (161-170 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|November 30, 2019
Which novel agents hold the greatest promise in AML?Courtney D DiNardoBest Practice & Research. Clinical Haematology|November 30, 2019
Beyond midostaurin: Which are the most promising FLT3 inhibitors in AML?Eunice S WangBest Practice & Research. Clinical Haematology|November 30, 2019
Does early diagnosis and treatment of myelodysplastic syndromes make a difference?David P SteensmaBest Practice & Research. Clinical Haematology|November 30, 2019
Acute myeloid leukemia: How to treat the fit patient over age 75?Selina M LugerBest Practice & Research. Clinical Haematology|December 6, 2020
The promise of macrophage directed checkpoint inhibitors in myeloid malignanciesDavid M Swoboda, David A SallmanBest Practice & Research. Clinical Haematology|December 6, 2020
Monoclonal antibodies in frontline acute lymphoblastic leukemiaSerena Chew, Nadya Jammal, Hagop Kantarjian, et al.Best Practice & Research. Clinical Haematology|December 9, 2022
Dysregulation of Protein S in COVID-19Martha M S Sim, Jeremy P WoodBest Practice & Research. Clinical Haematology|December 9, 2022
Vaccine-induced immune thrombotic thrombocytopeniaAdam J Kanack, Anand PadmanabhanBest Practice & Research. Clinical Haematology|December 9, 2022
A perspective on the sickle cell disease international COVID-19 registryLana Mucalo, Amanda M Brandow, Ashima SinghBest Practice & Research. Clinical Haematology|December 9, 2022
COVID-19 outcomes in sickle cell disease and sickle cell traitJana Christian, Sophie Lanzkron, Rakhi P NaikPageof 113